Clinical Research Office: Clinical Protocol and Data Management

The Markey Cancer Center (MCC) Clinical Research Office (CRO) coordinates and facilitates clinical cancer trials at the MCC. The major goals of the clinical trials office are to provide support of the clinical trial process, including implementing and regulating trials, provide a centralized clinical trial database, and integrate with the following: investigational pharmacy support, financial accounting, data safety monitoring, and quality assurance. The CRO also assists physician investigators in the design and subsequent conduct of clinical trials through its support of the Investigator Initiated Trial Protocol Development Unit. It performs all regulatory reporting and quality assurance needed to comply with good clinical practice in the performance of clinical trials.

View Active Cancer Trials.

The Markey Cancer Center is a full-member institute in multiple cooperative clinical trials groups of the National Cancer Institute, including:

NCI Comprehensive Cancer Center - A Cancer Center Designated by the National Cancer Institute

Markey Cancer Center is designated by the National Cancer Institute as a Comprehensive Cancer Center – a distinction that recognizes our commitment to accelerating precision cancer research and care to patients. We are the first and only NCI-Comprehensive Cancer Center in Kentucky, and one of 56 in the nation.